Technically Speakin...
Health Care: Drugs
Biosante Pharmaceuticals Inc. (BPAX: NASDAQ)
$2.22 -0.09 | -3.90%
06/04/12 - 11:29 AM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 57.23M | 38.16M | 29.86M | 11.76M |
| Receivables | 0.00 | 0.00 | 64.64K | 230.00K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 58.03M | 40.63M | 31.41M | 16.09M |
| Property, Plant & Equipment, Gross | 1.29M | 1.08M | 1.09M | 1.02M |
| Accumulated Depreciation & Depletion | 426.09K | 445.85K | 346.97K | 210.00K |
| Property, Plant & Equipment, Net | 861.36K | 635.78K | 747.98K | 815.00K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 3.49M | 3.51M | 4.28M | 777.00K |
| Total Non-Current Assets | 4.35M | 4.14M | 5.03M | 1.59M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 62.38M | 44.77M | 36.44M | 17.68M |
| Accounts Payable | 3.15M | 4.86M | 2.46M | 3.19M |
| Short Term Debt | 0.00 | 1.11M | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 7.23M | 8.18M | 3.93M | 3.85M |
| Long Term Debt | 17.34M | 17.44M | 16.68M | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 17.34M | 17.44M | 16.68M | 0.00 |
| Total Liabilities | 24.56M | 25.62M | 20.61M | 3.85M |
| Preferred Stock Equity | 391.00 | 391.00 | 391.00 | 0.00 |
| Common Stock Equity | 37.81M | 19.15M | 15.83M | 13.83M |
| Common Par | 255.05M | 184.78M | 135.26M | 85.73M |
| Additional Paid In Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -217.24M | -165.63M | -119.43M | -71.91M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 55.15M | 36.58M | 32.51M | 13.83M |
| Total Equity | 37.82M | 19.15M | 15.83M | 13.83M |
| Total Liabilities & Stock Equity | 62.38M | 44.77M | 36.44M | 17.68M |
| Total Common Shares Outstanding | 110.01M | 81.78M | 53.65M | 27.04M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 98.39M | 65.91M | 33.95M | 27.31M |
| Diluted Weighted Shares Outstanding | 98.39M | 65.91M | 33.95M | 27.31M |
| Number of Employees | 54 | 45 | 25 | 23 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with BPAX
- Portfolio NameUser Type
- UserSaveyn walter
- User2012_03
- Userwayne120
- ContributorBreakout Stocks Of The Week...
- UserDunDon1
- Contributor6 Drug Stocks Unworthy of B...
- Contributor3 Small-Cap Stocks on Insid...
- Contributor13 Biotech Stocks Bought an...
- UserSMITTY
- Contributor10 Most Shorted Stocks in B...
Latest BPAX Headlines from TheStreet
- Biosante Stock Gaps Down On Today's Open (BPAX) 06.01.12 | 09:06 am
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Transocean, Netflix, BioSante Are Market Movers 02.27.12 | 05:02 pm
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- Biosante Stock Falls On Unusually High Volume (BPAX) 02.07.12 | 11:02 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Market Preview: The Year Without a Santa Claus Rally 12.14.11 | 08:12 pm
- Novellus, BioSante: After-Hours Trading 12.14.11 | 07:12 pm
Press Releases for BPAX
- BioSante Pharmaceuticals, Inc. To Present At Jefferies Global Healthcare Conference - Business Wire 06.04.12 | 07:06 am
- BioSante Pharmaceuticals Announces Reverse Stock Split In Order To Maintain NASDAQ Listing - Business Wire 05.31.12 | 08:05 pm
- BioSante Pharmaceuticals Reports First Quarter Financial Results - Business Wire 05.08.12 | 04:05 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - PR Newswire 04.04.12 | 05:04 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.03.12 | 02:04 pm
- BioSante Pharmaceuticals Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of BioSante Pharmaceuticals, Inc. - Business Wire 03.29.12 | 05:03 pm
- BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation - Business Wire 03.20.12 | 07:03 am
- BioSante Pharmaceuticals Reports Financial Results For 2011 And Corporate Highlights - Business Wire 03.13.12 | 05:03 pm
- BioSante Pharmaceuticals, Inc. To Present At Roth Health Care Conference - Business Wire 03.09.12 | 07:03 am
- BioSante’s Prostate Cancer Vaccine Resulted In Stable Disease In Over 50% Of Patients In Newly Published Study - Business Wire 03.05.12 | 07:03 am
Partner Headlines for BPAX
- Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha 03.26.12 | 09:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- What BioSante's Balance Sheet Says About Future R&D - Seeking Alpha 03.01.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Singular Research Drops Coverage on BioSante Pharma After LibGel Results - Benzinga 12.16.11 | 04:12 pm
- Singular Research Reiterates BioSante Pharmaceuticals Buy, Maintains PT - Benzinga 12.13.11 | 01:12 pm
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
